I hold MRC CASE studentship with AstraZeneca and in the Faculty of Life Sciences based at the Manchester Institute of Biotechnology. My Phd research project is concentrated on understanding the Ras:Sos system that is key to the creation of new anti-cancer therapies. I am interested in examining and characterising the molecular interactions of the Ras:Sos system by various biophysical methods and computer-assisted data analysis in addition to the expression and purification of these proteins.
Thursday, 14 November 2013
Nanotechnology Researchers Prove Two-Step Method for Potential Pancreatic Cancer Treatment
A new biotechnology method for drug delivery that could improve the treatment of pancreatic cancer.
Pancreatic cancer is a deadly disease and is almost impossible to be detected the cancer is at an advanced stage. Treatment options for it are very limited in number and suffer low success rates.
The dual-wave nanotherapy method employed by Drs. Nel and Meng in their research uses two different kinds of microscopic particles (nanoparticles). The first injection of nanoparticles carries a substance that disrupts the cell signaling pathways and removes the vascular gates (caused by pericytes) that restricts access the pancreatic cancer cells. The second nanoparticle treatment carries the drug that kills the cancer cells.
Nanoparticles have been a popular source of drug treatment recently because it can reduce the toxicities and side effects when treating cancer.
For more information about the science and how they did it please see links below.
http://www.sciencedaily.com/releases/2013/11/131113092126.htm
http://www.globalbiotechrevolution.com/
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment